Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2023-01-01–present
Equibles does not estimate personal net worth.
Mark Cassebaum is recorded as CFO at Ascend Wellness Holdings, Inc. (AAWH) since November 27, 2023. Ascend Wellness Holdings, Inc. reported in an 8-K filed August 28, 2024 that Mark Cassebaum was terminated as Chief Financial Officer, effective August 26, 2024. Ascend Wellness Holdings, Inc. reported in an 8-K filed October 25, 2023 that Mark Cassebaum was appointed Chief Financial Officer, effective November 27, 2023. The proxy statement of Ascend Wellness Holdings, Inc. reports total compensation of $477,462 for Mark Cassebaum in fiscal 2023, including a base salary of $25,962. Ascend Wellness Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Ascend Wellness Holdings, Inc. includes Frank Perullo (CEO), Samuel Brill (CEO and Board Member), Abner Kurtin (Chairman and Board Member) and 7 others.
“On August 26, 2024, the Company terminated Mark Cassebaum as Chief Financial Officer of the Company, effective immediately.”
“On October 25, 2023, the Company announced the appointment of Mark Cassebaum as the new chief financial officer of the Company, effective November 27, 2023.”
2023-11-27–present
2023-01-01–2024-04-02
Last confirmed by a filing; no departure on record
Start not stated–2024-08-26
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Ascend Wellness Holdings, Inc. (AAWH) | Chief Financial Officer | $25,962 | $477,462 |